Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2025BiomoleculesOpen Access

Targeting Lactylation: From Metabolic Reprogramming to Precision Therapeutics in Liver Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

QTQinghai TanMLMei LiuXTXiang Tao

Discussion

Loading...

Member takes

Overview

This review demonstrates lactylation's impact on liver diseases, suggesting new therapeutic strategies to tackle metabolic reprogramming and inflammation.

Key Points

  • Lactylation influences tumor growth and treatment resistance by affecting metabolic pathways and the tumor microenvironment.
  • Aberrant lactylation worsens liver diseases, contributing to conditions like inflammation, fibrosis, and dysregulated lipid metabolism.
  • Therapies targeting lactate and lactylation enzymes show promise in preclinical models, indicating potential for future clinical applications.
  • Understanding lactylation's dynamics is crucial for developing precision therapies, as its role in liver health remains poorly defined.

Cite This Study

Tan et al. (2025) studied this question.

synapsesocial.com/papers/68af2ef6cf1dd9ea359e72d7https://doi.org/10.3390/biom15081178
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lactylation in cancer biology: Unlocking new avenues for research and therapy2025
  2. 2Advances and Deep Insights Into Lactylation: Essential Roles in Cellular Regulation and Disease Association.2025
  3. 3Roles of lactylation in lipid metabolism and related diseases2025
  4. 4Nonhistone lactylation: A hub for tumour metabolic reprogramming and epigenetic regulation2025
  5. 5Lactylation: a novel driver of drug resistance in the tumor microenvironment2025 · 12 citations